z-logo
open-access-imgOpen Access
Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting
Author(s) -
Falcão,
Carneiro,
Mendonça,
Sofia Fonseca,
Brandão,
Fernando FalcãoReis
Publication year - 2012
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s33017
Subject(s) - ranibizumab , medicine , bevacizumab , ophthalmology , macular degeneration , visual acuity , regimen , surgery , chemotherapy
We compared the efficacy of intravitreal ranibizumab and bevacizumab for treating neovascular age-related macular degeneration using an on-demand regimen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom